PD-1/TIM-3 repressed anti-GPC3 CAR T-cell therapy (Refuge Biotech)

N/A

Report date: 2025/01/26 18:54:18

Base Information

Drug NamePD-1/TIM-3 repressed anti-GPC3 CAR T-cell therapy (Refuge Biotech)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionGlypican-3 modulators

TargetsGlypican-3

Therapy Area/IndicationsLiver Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRefuge Biotechnologies Inc

China Registration ClassN/A

Develop Information

Active CompaniesRefuge Biotechnologies Inc

Inactive CompaniesN/A

Active IndicationsLiver Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A